Skip to main content
. 2009 Jan 22;23(4):572–583. doi: 10.1210/me.2008-0363

Table 1.

Effect of androgen treatment on DASL expression profile: androgen target genes

Gene symbol Fold induction
0.1 nm 1.0 nm
KLK2 6.552 9.633
MSMB 4.231 3.538
ACPP 0.649 1.100
TMPRSS2 1.924 3.408
ODC1 1.051 2.181
AMD1 1.100 1.179
SMS 1.166 1.198
SAT 1.056 1.251
ACACA 1.400 1.452
ACACB 2.336 0.813
ME1 1.317 1.699
FASN 0.880 3.797
HMGCS1 1.120 1.308
HMGCS2 1.516 1.862
HMGCR 1.097 2.052
DHCR24 1.783 4.296
FDPS 1.221 1.209
SREBF1 0.684 1.202
SREBF2 1.072 1.553
SCAP 1.094 1.294
INSIG1 1.310 2.351
INSIG2 0.721 0.604
ACTA2 1.327 4.317
ACTG2 2.180 5.963
MYL9 0.518 3.074
MYLK 0.275 0.294
TPM1 0.775 1.328
FN1 0.753 0.221
NKX3-1 2.133 2.749
CDK8 0.612 0.414
BCL2 1.207 0.769
CASP2 1.060 0.837
PIK3R3 0.917 0.467
RAB4A 1.072 1.333
LIFR 1.156 3.006
HERC3 1.413 3.013
VEGFA 1.025 3.006
VEGFC 2.357 0.904
NDRG1 1.358 5.378
NFKBIA 0.869 1.167
BCHE 0.763 0.306
AR 0.526 0.407

The order of the genes listed corresponds to the order in which the genes are listed and grouped in the heatmap shown in supplemental Fig. 1. LNCaP cells were seeded in medium supplemented with charcoal-stripped serum. Medium was changed 3 d later, and cells were treated with 0, 0.1 or 1 nm of R1881. Cells were harvested 48 h later, and RNA was isolated and subjected to DASL analysis. Values represent the average fold change in gene expression after treatment with 0.1 or 1 nm of R1881 from three biological replicates each.